Drug Shortage Report for TRILEPTAL 300 MG

Last updated on 2020-11-24 History
Report ID 128180
Drug Identification Number 02242068
Brand name TRILEPTAL 300 MG
Common or Proper name TRILEPTAL FCT 300MG 5 X 10
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) OXCARBAZEPINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 5 X 10
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-11-06
Actual start date 2020-11-06
Estimated end date 2020-11-30
Actual end date
Shortage status Actual shortage
Updated date 2020-11-24
Company comments Demand increase due to generic backorder. Limited stock available being allocated based on customer profile.
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-11-24 French Compare
v9 2020-11-24 English Compare
v8 2020-11-23 French Compare
v7 2020-11-23 English Compare
v6 2020-11-23 French Compare
v5 2020-11-23 English Compare
v4 2020-11-19 French Compare
v3 2020-11-19 English Compare
v2 2020-11-09 French Compare
v1 2020-11-09 English Compare